Medea Biopharma GmbH specializes in the development of a new generation of sustainable and eco-friendly antibacterial solutions based on bacteriophages (phages), designed to solve the global crisis of antimicrobial resistance. 

Phages are natural bacterial killers, which are highly specific and without side effects. These innovative alternatives aim to replace conventional chemical antibiotics, copper-based solutions, and harmful pesticides, offering effective and environmentally responsible ways to combat harmful bacteria across diverse sectors, including human health, animal wellbeing, and agriculture.